The global pharmaceutical market was estimated in USD 1.1 trillion in 2016. The global market is highly mature and consolidated. The top-10 pharmaceutical companies in this market had share of around 40% in 2016 and approximately 50% considering the top-15. A comparative analysis of the top-15 organizations was used to develop a ranking for these companies.
The ranking model incorporated seven criteria for each organization with focus on revenues generated by pharmaceutical products and growth in pharmaceutical revenues (2015-2016). These additions emphasizes on the company’s pharma product portfolio unlike last year’s ranking which was based on company’s overall growth. The criteria includes pharmaceutical revenues, annual pharmaceutical revenue growth, total R&D expense, total expense, total income, proportion of revenue from top three pharmaceutical products and revenue per employee. A score statistic was developed based on these criteria. Each company was assigned a score for each criteria and a weighted sum was used to arrive at the final score statistic. Pharmaceutical revenue received the highest weight (40%) while revenue per employee (6%) receive the lowest. The score statistic represented the pharmaceutical financial health and diversity of product portfolio of each company.
Pfizer is a research-based pharmaceutical company engaged in the wellness, prevention and treatment for diseases across a broad range of therapeutic areas. The company operates through Innovative Health and Established Health businesses.
Merck, known as MSD outside the United States and Canada, offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
Johnson & Johnson (J&J) and its subsidiaries are engaged in the research, development, manufacture and sales of pharmaceuticals, medical devices and consumer health products.
Hoffmann-La Roche (Roche) develops, manufactures and deliver innovative therapeutics and diagnostic instruments and tests.
Sanofi is a French life science company involved in research, development, manufacture and marketing of therapeutic solutions.
Novartis is a global healthcare company based in Basel, Switzerland. The company’s portfolio includes innovative pharmaceuticals and oncology medicines, generic and biosimilar medicines and eye care devices.
AbbVie, the Illinois-based company develops and markets therapies focused on treating rheumatology, gastroenterology, dermatology, oncology, virology, neurological disorders and metabolic diseases conditions.
AstraZeneca is a global company involved in the discovery, early- and late-stage development to manufacturing and distribution, and the global commercialization of primary care, specialty care-led and specialty care medicines.
Gilead is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicine with focus on virology, hepatology, hematology, oncology, cardiovascular, inflammation and respiratory diseases.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
Sources: SEC filings and annual reports.